跳至主要内容
临床试验/NL-OMON40314
NL-OMON40314已完成不适用

Six-Month Clinical and Angiographic Follow up of Everolimus eluting bioresorbable vascular scaffold in patients presenting with ST-segment elevation myocardial infarction - BVS-STEMI

Erasmus MC, Universitair Medisch Centrum Rotterdam0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • 1. Patient is at least 18 years of age.
  • 2. Patient has been treated, within the previous 6 month, with BVS for primary PCI .
  • 3. For the pre-specified subgroup of 30 patients, an OCT study of the treated culprit lesion after BVS implantation should be available for analysis.
  • 4. Treated target lesion must be a de-novo lesion located in a native vessel.
  • 5. Signed Informed Consent.
  • 6. The patient understands and accepts the meaning and the aims of the study

排除标准

  • 1. Pregnancy.
  • 2. Known intolerance to contrast material.
  • 3. Known thrombocytopenia (PLT< 100,000/mm3).

研究者

相似试验